Comparison of pharmacokinetic characteristics of two Tegoprazan (CJ-12420) formulations in healthy male subjects

Proton-pump inhibitors (PPIs) are effectively used to treat acid-related diseases, including gastroesophageal reflux disease (GERD); however, many unmet medical needs still exist. As a new treatment option, potassium-competitive acid blockers (P-CABs), such as tegoprazan, have been developed. This s...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Transl Clin Pharmacol
Egile Nagusiak: Hwang, Jun Gi, Yoo, Hyounggyoon, Lee, Ji Won, Song, Geun Seog, Lee, SeungHwan, Kim, Min-Gul
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Korean Society for Clinical Pharmacology and Therapeutics 2019
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6989242/
https://ncbi.nlm.nih.gov/pubmed/32055586
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12793/tcp.2019.27.2.80
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak